# A Study of LY2541546 in Women With Low Bone Mineral Density

> **NCT01144377** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 154 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** LY2541546
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01144377
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-05
- **Final completion:** 2013-02
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144377, "A Study of LY2541546 in Women With Low Bone Mineral Density". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01144377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*